0001179110-16-020662.txt : 20160302
0001179110-16-020662.hdr.sgml : 20160302
20160302170403
ACCESSION NUMBER: 0001179110-16-020662
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160229
FILED AS OF DATE: 20160302
DATE AS OF CHANGE: 20160302
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOANALYTICAL SYSTEMS INC
CENTRAL INDEX KEY: 0000720154
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 351345024
STATE OF INCORPORATION: IN
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 2701 KENT AVE
CITY: WEST LAFAYETT
STATE: IN
ZIP: 47906-1382
BUSINESS PHONE: 3174634527
MAIL ADDRESS:
STREET 1: 2701 KENT AVENUE
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906-1382
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lemke Jacqueline M
CENTRAL INDEX KEY: 0001546217
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23357
FILM NUMBER: 161477939
MAIL ADDRESS:
STREET 1: 2701 KENT AVENUE
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906
4
1
edgar.xml
FORM 4 -
X0306
4
2016-02-29
0
0000720154
BIOANALYTICAL SYSTEMS INC
BASI
0001546217
Lemke Jacqueline M
2701 KENT AVENUE
WEST LAFAYETTE
IN
47906
1
1
0
0
President and CEO
Common Shares
2016-02-29
4
P
0
4000
1.1854
A
60685
D
Common Shares
2016-02-29
4
P
0
6000
1.17
A
9000
I
See Footnote
The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.13 to $1.20, inclusive. The reporting person undertakes to provide Bioanalytical Systems, Inc., any security holder of Bioanalytical Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The reporting person acts as custodian for accounts which hold these shares for the benefit of the reporting person's minor children. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.
/s/ Jill Blumhoff, attorney-in-fact for Jacqueline M. Lemke
2016-03-02